Abstract. Coenzyme Q is a lipid molecule required for respiration and antioxidant protection. Q biosynthesis in Saccharomyces cerevisiae requires nine proteins (Coq1p-Coq9p). We demonstrate in this study that Q levels are modulated during growth by its conversion from demethoxy-Q (DMQ), a late intermediate. Similar conversion was produced when cells were subjected to oxidative stress conditions. Changes in Q 6 /DMQ 6 ratio were accompanied by changes in COQ7 gene mRNA levels encoding the protein responsible for the DMQ hydroxylation, the penultimate step in Q biosynthesis pathway. Yeast coq null mutant failed to accumulate any Q late biosynthetic intermediate. However, in coq7 mutants the addition of exogenous Q produces the DMQ synthesis. Similar effect was produced by over-expressing ABC1/COQ8. These results support the existence of a biosynthetic complex that allows the DMQ 6 accumulation and suggest that Coq7p is a control point for the Q biosynthesis regulation in yeast.
Introduction
Coenzyme Q (ubiquinone, Q) is an isoprenylated benzoquinone involved in respiration [1] , and in the defense against oxidative stress [2] . The location of Q biosynthesis may depends on the organism analyzed. It is synthesized in mitochondria and then distributed among the other membranes of the cell through the endomembrane system pathway in human cells [3] . Saccharomyces cerevisiae shares with human cells the same location based on the presence of mitochondrial import signals and also its mitochondrial localization by immunolocalization analysis [4] . However, other locations have been reported for mammalian cells [5, 6] and in pathogenic fungus such as Pneumocystis sp. [7, 8] . The number of isoprenoid units (n) in the polyprenyl tails of Q n varies depending on the species; humans produce Q 10 , Saccharomyces cerevisiae produce Q 6 , and Caenorhabditis elegans produce Q 9 . Addition of exogenous Q with different tail lengths can augment respiration, but may also induce oxidative stress in mitochondria [3] and impact longevity [9] [10] [11] , indicating that Q may affect a variety of cellular pathways [12] . At least nine genes are involved in Q biosynthesis in the yeast S. cerevisiae (COQ1-COQ9) [13, 14] . As is shown in Figure 1 , the protein products of some of these genes have known catalytic functions in eukaryotic Q biosynthesis, but the function of Coq4, Coq6, Abc1/Coq8, and Coq9 still require characterization [13, [15] [16] [17] . In yeast coq null mutants (coq3-coq9), 3-hexaprenyl-4-hydroxybenzoic acid (HHB) is the only Q biosynthetic intermediate detected [13, 15, 18, 19] . It is possible that this result can be explained because most of the other Q-intermediates are rapidly degraded, but a growing body of evidence suggests interactions among Coq proteins lead to formation of a Qbiosynthetic complex [20] [21] [22] 23] . However, little is known about the regulation of this pathway in eukaryotic cells. A decrease of the antioxidant atocopherol induces Q biosynthesis in rat liver [24] , and calorie restriction maintains the Q 10 /Q 9 ratio in longlived rats compared to those fed ad libitum [25] . Nevertheless, molecular mechanisms involved in this regulation are still unknown [17] . Yeast coq7 null mutants accumulate HHB, but yeast strains harboring coq7 point mutations that lead to amino acid substitutions G 104 D or E 194 K also produce 2-hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone (demethoxy-Q 6 , or DMQ 6 ) [26, 27] . This intermediate is also accumulated in C. elegans clk-1 mutants [28] and clk-1/coq-7 knockout mice [29] . Both mutants fail to complete development, although dietary Q partially rescues C. elegans clk-1 mutants [30, 31] . DMQ 6 fails to support both respiration and antioxidant functions in S. cerevisiae, but because a small amount of this intermediate is accumulated in wild-type yeast, it may have a specific function in the Q biosynthetic pathway [32] . Here we show that DMQ 6 is accumulated during early log phase of growth of S. cerevisiae. We investigate mechanisms responsible for changes in the cellular content of Q 6 and DMQ 6 during growth and in response to oxidative stress. The findings presented here support a model describing two phases of Q biosynthesis. The first phase requires the interactions of several of the Coq polypeptides, and Q 6 itself, to produce DMQ 6 . The second phase is defined by the conversion of DMQ 6 to Q 6 , and this conversion is regulated by growth phase and by linolenic acidinduced oxidative stress. Scheme of coenzyme Q 6 biosynthesis. HHB (3-hexaprenyl-4-hydroxybenzoic acid) is produced by the action of COQ1 and COQ2 proteins. HHB is converted to 3,4-dihydroxy-5-hexaprenylbenzoic acid (DHHB) by an unidentified enzyme. The Omethyltransferase encoded by COQ3 catalyzes the next step to produce 3-methoxy-4-hydroxy-5-hexaprenylbenzoic acid. Several modifications of the head group results in 5-demethoxyubiquinone (DMQ 6 ). Coq7p, a monooxygenase, converts DMQ 6 to 5-demethylubiquinone, which is methylated again by the Coq3p O-methyltransferase to produce Q 6 .
Materials and Methods
Yeast strains and growth media. Yeast strains used in this study are shown in Table 1 . Growth media for yeast was prepared as described [33] and included YPD (1 % yeast extract, 2 % peptone, 2 % dextrose), YPD10 (YPD containing 10 % glucose instead of 2 %), YPG (1 % yeast extract, 2 % peptone, 3 % glycerol), SDC (0.18 % yeast nitrogen base without amino acids, 2 % dextrose, 0.14 % NaH 2 PO 4 , 0.5 % (NH 4 ) 2 SO 4 , and complete amino acid supplement), and SD-Ura (SDC, but amino acid supplement lacks uracil). Yeasts were grown at 30 8C with shaking (200 rpm). Plasmid pMCOQ4 was created by digesting the plasmid pTL4 [15] with BamHI and ligating the fragment to pRS426 that had been similarly treated. Plasmid pMABC1 was created by digesting the plasmid p3HN4 [16] with SalI and NotI and ligating the fragment with pRS426 that had been similarly treated. pMCOQ4 and pMABC1 plasmids were used to transform the CEN.MP3 -1A yeast strain using the lithium acetate-PEG method [34] .
Oxidative stress treatment. Yeast cells were cultured in YPD10 overnight (OD 600nm = 9-10), washed and resuspended in sterile 100 mM sodium phosphate buffer, pH 6.2, with 0.2 % glucose, at 180 x 10 6 cells/ml. Cell suspensions were incubated with 1 mM H 2 O 2 , 750 mM oleic acid, or 750 mM linolenic acid for four hours.
In vivo labeling of Q 6 and Q 6 -intermediates. p-[U- C-dpm/ml of medium).
Identification of Q 6 and Q 6 -intermediates by HPLC/ ECD. Lipid extractions of whole cells and quantification of Q 6 and Q 6 -intermediates were performed as described [35] . Coenzyme Q 9 was used as an internal standard; 1 mg Q 9 was added per g wet weight cell pellet. Lipid components were separated with a Beckmann 166 -126 HPLC system equipped with a 15 cm Kromasil C-18 column in a column oven set to 40 8C, with a flow rate of 1 ml/min and a mobile phase containing 88/24/10 methanol/ethanol/2-propanol and 13.4 mM lithium perchlorate. Quinones were quantified with an ESA Coulochem III electrochemical detector (ECD) and a 5010 analytical cell (E1, -500mV; E2, +500mV). Hydroquinones present in samples were oxidized with a pre-column cell set in oxidizing mode (E +500mV). Q 6 and Q 9 were quantified with external standards.
RPHPLC-APCI-MS/MS multiple reaction monitoring analysis. One gram wet weight pellets of yeast strains as indicated were harvested at 44 hours (14 -26 OD/ml) harvested from YPgal media: (2 % galactose, 0.1 % dextrose) and collected by centrifugation at 1000 x g in 50 ml tared borosilicate glass conical tubes with Teflon-lined caps. These were stored at -20 8C until extraction. Samples were thawed on ice, and 183 pmol of internal standard was added (Q 4 , Sigma) to samples and standards. This was followed by 1 ml water and 16 ml hexane/2-propanol (3/2, v/v) [36] . After shaking at 200 rpm for 10 minutes the samples were vortexed vigorously for ten seconds and the phases were allowed to separate while standing at room temperature. The upper phase was removed to a 50 ml amber glass vial. The lower phase was reextracted with hexane:2-propanol; 7:2 (8 ml) twice and the pooled organic phases were concentrated by vacuum centrifugation and stored dry at -20 8C. The four point standard curve (7.8 fmol/ml to 1.01 pmol/ml) was extracted simultaneously with the cell pellet samples. Dried samples and standards organic extracts were resuspended in 400 ml neat ethanol. These crude lipids were separated (50 ml/injection) by a reverse phase column Thermo Hypersil (Keystone Scientific Operations) BetaBasic 18, 4.6 x 250 mm, 5 m particle size) equilibrated in water/acetonitrile (50/50 (v/v); solvent A) and eluted (1 ml/min ml/m) with an increasing concentration of 100 % acetonitrile; solvent B (min/% acetonitrile: 0/90; 3/90; 7/100; 30/100). The eluate was passed directly into an atmospheric pressure chemical ionization source (APCI, nebulizing gas, "zero"-grade air produced by a Zero Air Generator (Peak Scientific, Chicago, Il) at 2-3 L/s, nebulizer 450 8C, orifice 50 volts) attached to a Perkin-Elmer Sciex (Thornhill, 6 , m/z 561.4 ! 167.0) with dwell set to 1000 ms, a pause time of 0.3 ms and a total scan time of 4.0 seconds. Standards (DMQ 3 and Q 3 ) were fragmented and used to confirm the identity of the ions. Synthesis of DMQ 3 was as described [22] . MRM peak areas were measured by instrument manufacturer supplied software (MacSpec, version 3.3, PE Sciex, Ontario, Canada). The calibration curve from the extracted set of standards (ordinate, Q 6 /Q 4 peak area ratio; abscissa, Q 6 amount) had correlation coefficient (r 2 ) of 0.99 with slope = 4.68 (intercept forced to zero). Concentrations of Q 6 and DMQ 6 (in Q 6 equivalents) present in the extracts were directly interpolated from the calibration curve, and quantities in each fraction were calculated after correction for dilution and amount assayed. Lipid extractions and analyses were completed on independent replicate yeast pellets and were injected twice. The data presented represent independent replicate cell pellets and duplicate LC/MS-MS analyses.
RNA isolation and cDNA synthesis. Cells (200 x 10 6 ) were harvested by centrifugation and washed twice in DEPC-treated water. Cells were resuspended in 200 ml 20 mM Tris-HCl, pH 7.4, with 30 % glycerol, frozen in N 2 (l) and stored at -80 8C until use. For total RNA isolation, cells were thawed and washed with DEPCtreated water. Each cell pellet was resuspended in 500 ml cell-wall-digestion buffer (50 mM potassium phosphate, pH 7.4, 10 mM DTT) and incubated 45 min at 30 8C in the presence of 10 ml Zymolyase 20T, 10 mg/ ml (Seikagaku Corporation, Japan). Spheroplasts were collected by centrifugation and total RNA was isolated (Eppendorf Perfect RNA Eukaryotic Mini kit) and quantified with a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DL USA). cDNA was synthesized from 1 mg of total RNA in a 20 ml reaction containing Moloney Murine Leukemia Virus (M-MuLV) reverse transcriptase buffer, 40 U M-MuLV, 1 mM dNTP mix, 20 U RNase inhibitor (Fermentas Life Sciences, Vilnius, Lithuania) and 500 ng oligo(dT) from MWG, Ebersberg, Germany. Each reaction was performed for 1 h at 42 8C according to manufacturers directions.
Primers and DNA competitors. Primers were designed with Primer Premier 5.00 software (Premier Biosoft International, Palo Alto, CA, USA) and the available sequence information from SGD yeast database (Table 2 ). For each gene analyzed, a competitor fragment was generated with recombinant PCR. The competitor fragment was amplified from genomic DNA [33] with the competitor primers (i.e. ABC1-ComF and ABC1-ComR). These primers contain the 5 and 3 specific ends of the sequence used as competitor and a tail corresponding to the sequence of primers used to amplify the target gene (i.e. ABC1-U210 and ABC1-L1260). The competitor was cloned in a T-hang vector such as pMBL (Dominion-MBL SL, Córdoba, Spain) and sequenced to confirm the construct (MWG, Ebersberg, Germany). The target gene fragment was also cloned in the same vector. For analyses of the COQ genes, the ACT1 gene was used as a competitor. For analyses of the ACT1 gene (used as calibrator) the COQ5 gene was used as competitor. The competitor required for expression analyses was amplified by PCR with the appropriate target primers, extracted from agarose (Eppendorf Perfect Gel Cleanup), and quantified by absorbance spectrophotometry. The designated competitor DNA products were prepared and purified freshly for each set of experiments.
Amplification kinetics and determination of the optimal concentration of the competitor DNAs. To test the quality of competitor, each target-competitor pair (0.1 attomol) were used as template for the PCR in the presence of target primers. Samples were removed at the specified cycle number (from cycles numbered 23 to 30), and resolved by agarose gel electrophoresis ( Fig. 2A) . Both competitor and target specific DNA fragments were quantified with a gel analyzer (Gel Doc 1000, Bio-Rad Laboratories, Hercules, CA, USA). Data obtained were subjected to linear regression analysis validating the effectiveness of each competitor (Fig. 2B) . In order to determine the optimal amount of competitor 10-fold serial dilutions of competitor (100 -0.1 attomol) were amplified together with constant aliquots (2 ml) of cDNA from the wild-type strain CEN.PK2-1C with target primers and PCR samples were resolved by agarose gel electrophoresis (Fig. 2C) . Band in-tensities were quantified and expressed as arbitrary units (AU). After a correction depending of the fragment size, the base-10 logarithm of the target/ competitor ratio was calculated. The ratios were plotted against the logarithm of the amount of competitor added (Fig. 2D ). This plot was used to calculate the equivalence point, the point in which the logarithm of the ratio target/competitor is equal to 0 (target concentration equal to competitor concentration). The measured concentration of the competitor determined the concentration to be used in the expression analysis experiments.
Competitive RT-PCR expression analyses. Samples of yeast cDNA (2 ml from a 20 ml reaction containing 1 mg of total yeast RNA) were amplified together with constant amounts of competitor in a volume of 25 ml. PCR reaction mixtures were resolved by agarose gel electrophoresis and the band intensities were used to calculate the logarithm of the ratio target/competitor. Differences in these ratios indicate differences in expression. Competitive RT-PCR expression method was performed as was described with minor modifications [37, 38] .
Results DMQ 6 is a predominant Q 6 -intermediate in log phase yeast cultures. To study the regulation of Q 6 biosynthesis in yeast, we first analyzed the concentrations of both DMQ 6 and Q 6 throughout the growth in both non-fermentable (YPG) (Fig. 3A) and fermentable (YPD) media (Fig. 3B ). The Q 6 /DMQ 6 ratio was significantly decreased (from 4.0 to 0.5) during the first 10 h culture in YPG culture, due to the transient accumulation of DMQ 6 (Fig. 3A and 3C ). The amount of DMQ 6 was surprisingly persistent; even after 24 and 48 hours of culture the content of DMQ 6 remained high. Yeast grown in YPD showed also a transient increase in DMQ 6 content; the Q 6 /DMQ 6 ratio decreased from 4.4 to 2.0 over the first 10 h. This Table 2 . Primers used in this work.
Research Article trend was then reversed by the increase in Q 6 content yielding a ratio of 5.0 by 24 h (Fig. 3B ).
Changes in COQ RNA levels as a function of growth phase and culture. Results showed above suggest the existence of a biochemical mechanism through yeast cells could regulate Q 6 biosynthesis by modulation of DMQ 6 to Q 6 transformation rate. To further investigate this process mRNA levels of several genes involved in Q 6 biosynthesis pathway (COQ genes) were determined. Seven of the nine COQ genes products in yeast (Coq3-Coq9) are required for ring modification of Q 6 molecule [20, 21, 23] and Coq7p is the enzyme involved in DMQ 6 hydroxylation (Fig. 1) . Therefore, mRNA levels of COQ3, COQ4, COQ5, COQ7 and ABC1 genes were measured in yeast grown in YPG and YPD media ( Fig. 3A and 3B ). In general COQ RNA levels are higher in yeast grown in YPG (Fig. 4A) . COQ7, ABC1/COQ8, COQ5, and COQ3 RNA levels tend to increase (from 2-to 7-fold) with time in culture. Changes in COQ RNA levels as a function of growth phase in YPD media are fairly modest (Fig. 4B) , however, COQ7 RNA levels were significantly elevated as cells transit from log to stationary phase. These results suggest that there are at least two phases in Q 6 biosynthesis; one leading to DMQ 6 biosynthesis driven by a slow increase of the expression of COQ genes, and a second phase, driven by the expression of COQ7, where the final ring hydroxylation and methylation steps produce Q 6 .
The conversion of DMQ 6 to Q 6 responds to oxidative stress. Previous studies have demonstrated antioxidant properties of coenzyme Q. Yeast strains that are unable to synthesize Q 6 or producing only DMQ 6 are very sensitive to oxidative stress induced by H 2 O 2 and linolenic acid [32, 39] . Therefore, yeast cells under oxidative stress conditions could potentially activate . In order to determine the optimal amount of competitor DNA, 10-fold serial dilutions of competitor (100 -0.001 attomol) were added to a constant amount of cDNA from the wild-type strain CEN.PK2 -1C (2 ml from a 20 ml RT-PCR reaction made with 1 mg total RNA). The primers ABC1-U210/ABC-L1260 were added, PCR performed, and the DNA products resolved by agarose gel electrophoresis (C). The logarithm of the ratio of the ABC1 fragment and the ABC1 competitor fragment was plotted against the logarithm of ABC1 competitor (D). The equivalence point corresponds to the competitor concentration that produces a ratio equal to zero. The amount indicated is the amount of competitor added in subsequent experiments to quantify ABC1/COQ8 RNA levels.
Q 6 synthesis in order to increase protection from oxidative damage. To test this hypothesis, in yeast subjected to oxidative stress we have analyzed the content of Q 6 and DMQ 6 in the wild-type CEN.PK2 -1C yeast strain treated with H 2 O 2 , oleic acid, or linolenic acid. This wild-type strain was highly resistant to treatment with either 1 mM H 2 O 2 or 750 mM linolenic acid [32] . Figure 5A shows that the Q 6 /DMQ 6 Research Article concentration as linolenic acid, oleic acid treatment does not produce significant changes in the Q 6 and DMQ 6 levels. To investigate whether the oxidative stress treatments affected COQ gene expression, we analyzed the steady state COQ RNA levels. Linolenic acid, but neither H 2 O 2 nor oleic acid, increased both COQ7 and COQ3 RNA levels following a 4 h treatment relative to control (Fig. 5B) . Other COQ RNA levels examined did not change significantly, including COQ5, in response to oleic acid treatment (Fig. 5B) . These results suggest that treatment with linolenic acid acts to increase COQ7 and COQ3 RNA levels, and acts to enhance the conversion of DMQ 6 to Q 6 as a mechanism to provide antioxidant protection. Figure S1B ) were resolved by electrophoresis on a 1 % TBE agarose gel, and densitometry analyses were performed according to Experimental Procedures. Expression data for YPG (A) and YPD (B). Symbols correspond to COQ3 (*), COQ4 (*), COQ5 (q), COQ7 (r) and ABC1 (&). ACT1 RNA levels were used to normalize each of the COQ RNAs, and corrections were made to account for effects of fragment size. Data correspond to the average of two independent PCR reaction AE SD using the same total RNA sample. This experiment is representative of a set of three. Figure 5 . COQ RNA levels and content of Q 6 and DMQ 6 in response to oxidative stress. CEN.PK2 -1C cells were subjected to different oxidative stress conditions (1mM H 2 O 2 , or 750 mM linolenic acid) or to control treatments (no addition, or 750 mM oleic acid) for four hours. Cells (900 x 10 6 ) were collected and analyzed for quinone content as described (A; Q 6 , black bars; DMQ 6 , gray bars). About 200 x 10 6 cells were collected to determine COQ RNA content (Fig. S1C) , and densitometry data were plotted to calculate gene expression (B). Bars correspond (from white to black) to COQ3, COQ4, COQ5, COQ7 and ABC1/COQ8 genes. Control, cells without oxidative stress treatment; H, 1mM H 2 O 2 incubation; LA, 750 mM linolenic acid; OA, 750 mM oleic acid. RNA levels presented are from the average of two independent PCR reactions AE SD derived from the same total RNA sample. Data are representative of two similar experiments. DMQ 6 can be synthesized in yeast in the absence of Coq7p. Yeast strains harboring null mutations in one of the COQ genes (COQ3 to COQ9) accumulate HHB (3-hexaprenyl-4-hydroxybenzoic acid), an early Q-intermediate that is the product of the reaction carried out by Coq2p [13, 26, 41, 42] . Several lines of physical evidence now indicate the existence of a biosynthetic Coq-polypeptide complex inside mitochondria [22] . Supplementation of growth media with exogenous Q 6 has been shown to rescue mitochondrial respiration in the yeast coq mutants [43] and to preserve steady state levels of Coq3 and Coq4 polypeptides [27] of a coq7 null mutant. In addition, it has been shown that Q 6 and DMQ 6 are associated with a polypeptide complex defined by Coq3p and Coq4p products [22] . This latter observation suggests that interaction between Q 6 and COQ genes products could be important for the biosynthetic complex stabilization and regulation of Q 6 biosynthesis. To determine whether the functional interaction among Coq polypeptides depends on the presence of Q 6 , we analyzed the effect of addition of exogenous Q 6 on coq null mutants growing in YPD. The analysis of lipid extracts from each of the coq mutants (coq3-abc1/ coq8) indicated that a product co-eluting with DMQ 6 was produced only in the coq7 mutant strain cultured in the presence of exogenous Q 6 (Fig. S3) . To identify the material co-eluting with DMQ 6 , we performed RP-HPLC/MS-MS analysis of the lipid extracts prepared from the wild-type parental strain and the coq7 null mutant cultured in the presence and absence of exogenously added Q 6 . As described in experimental procedures, quantitative data was collected in the multiple reaction monitoring (MRM) mode. This method separates lipid extracts, producing specific retention times for the compounds of interest; the detection of the lipids involves selection of a specific precursor (parent) molecule, which is fragmented for quantification of a specific product (daughter) molecule. By these criteria the Q 6 and DMQ 6 content in the CEN.PK2 -1C wild-type yeast were 62.73 AE 15.13 and 4.22 AE 1.04 pmol/gm wet weight, respectively. Neither Q 6 nor DMQ 6 were present at measurable amounts in the coq7 null yeast strain. However, when cultured in the presence of exogenous Q 6 , the coq7 null mutant contained quantities of both Q 6 (8.05 AE 3.16 pmol/gm wet weight) as well as DMQ 6 (0.24 AE 0.10 pmol/ gm wet weight). To determine whether the DMQ 6 produced by the coq7 mutant represented de novo synthesis, several of the coq null mutant strains were grown in the presence of [ 14 C]-pHB, the aromatic ring precursor, and in the presence or absence of exogenously added Q 6 . Supplementation of the growth media with exogenously added Q 6 did not affect the incorporation of [ 14 C]-pHB into either DMQ 6 or Q 6 in the wild-type strain (Fig. S4) . Similar incubations of the coq3 and abc1 null mutant strains showed that neither produced detectable DMQ 6 or Q 6 , and each produced only a more polar radiolabeled peak eluting at about 6 min, as predicted for HHB (Fig. 6A and C) . However, a significant radiolabeled peak corresponding to [ 14 C]-DMQ 6 was observed in lipid extracts prepared from the coq7 null mutant strain following incubation with [ 14 C]-pHB plus exogenous Q 6 (Fig. 6B) . Because growth of the coq7 null mutant in the presence of exogenous Q 6 leads to uptake of Q 6 [44] , these results indicate that Q 6 itself supports interaction of the Coq proteins and enables de novo synthesis of DMQ 6 . Thus, Q 6 is a crucial lipid component of the Coq polypeptide biosynthetic complex, and its presence may be required to facilitate formation of, and/or stabilize, the Coq polypeptide biosynthetic complex. COQ RNA levels were quantified in the CEN MP3.1A (coq7 null) strain in response to culture in the presence or absence of exogenous Q 6 (Fig. 7) . Addition of exogenous Q 6 did not produce a change in COQ3, COQ4, COQ5, or ABC1/COQ8 RNA levels, indicating that the de novo synthesis of DMQ 6 is not driven by changes in RNA levels. Recent studies show that exogenously added Q 6 to coq7 null mutant cultures enhanced the steady state levels of the Coq3 and Coq4 polypeptides [27] . Hence, it is likely that the addition of Q 6 acts to stabilize the Coq polypeptides.
Abc1p and Coq4p regulate DMQ 6 synthesis. To further understand whether there are more factors involved in the stabilization of Coq polypeptides, we analyzed whether an alteration of the expression of certain Coq proteins would lead to complex stabilization and DMQ 6 synthesis in a coq7 null mutant strain. Of the COQ genes participating in the synthesis of DMQ 6 , Coq4p and Abc1/Coq8p do not have an assigned function, although Abc1/Coq8p has recognized sequence motifs that identify it as a potential Hanks Ser/Thr protein kinase [17, 45] . To study the possible functions of Coq4p and Abc1/Coq8 in DMQ 6 biosynthesis, the yeast coq7 null mutant strain was transformed with a multi-copy plasmid harboring either COQ4 or ABC1 coding sequence including the natural promoter. The over-expression of COQ4 or ABC1 in the coq7 null mutant does not produce significant changes in the expression of other COQ genes (Fig. 8A) . Lipid extracts of these cells were analyzed for content of Q 6 and DMQ 6 by HPLC-ECD. Multicopy expression of COQ4 produces the synthesis of a small amount of DMQ 6 as compared with the coq7 null mutant strain; however, the multicopy expression of ABC1/COQ8 increases dramatically the amount of DMQ 6 , to levels much higher than detected in wildCell. Mol. Life Sci.
Vol. 66, 2009 Research Article type cells (Fig. 8B) . These results support a regulatory function for Abc1/Coq8p; and indicate that overexpression of Abc1/Coq8p can facilitate the formation of a Coq7p-independent complex for DMQ 6 biosynthesis in S. cerevisiae.
Discussion
Several lines of evidence presented here suggest that hydroxylation of DMQ 6 may serve as a control point in the biosynthesis of Q 6 . DMQ 6 is a predominant intermediate in log phase yeast cells. As cells transition from log to stationary phase growth, the DMQ 6 content decreases and the Q 6 content increases. This regulatory point of coenzyme Q biosynthesis is not the only in yeast, another regulatory point may be related for the protein Coq2p. Previous studies [46] have shown that, in yeast cultured with increased concentrations of glucose, a decrease of Q 6 and DMQ 6 levels resulted, while HHB increased. This supports the idea of an initial and strong regulatory point based in a phosphorylation cycle, linked to the fermentative growth phase in yeast. To investigate whether the control of the content of DMQ 6 and Q 6 is due to changes in gene expression, COQ RNA levels were . Q 6 supplementation does not affect COQ RNA content in the coq7 null mutant. The CEN.MP3 -1A strain (coq7) was cultured in YPD in the presence (+Q 6 ) or absence (-Q 6 ) of exogenous Q 6 (2 mM). Total RNA was isolated and the content of COQ RNA was determined as previously described (Fig. S2A) . Densitometry data were plotted to calculate RNA levels in the absence (black bars) or presence (white bars) of Q 6 supplementation.
quantified. COQ RNA levels were generally higher in cells grown in media containing glycerol (YPG) as compared to dextrose (YPD). This has been observed previously [15, 47, 48] . In YPG media COQ7, ABC1/ COQ8, COQ5 and COQ3 RNA levels increased (from 2-to 7-fold) as cells transitioned from log to stationary phase. In contrast, COQ RNA levels in YPD media stay fairly constant, except for COQ7 RNA levels, which increase about 5-fold in stationary phase cells as compared to log phase. The data suggest that Q 6 synthesis may take place in two phases; the first phase produces DMQ 6 as a predominant intermediate, and the second phase is driven by the induced expression of the COQ7 gene, which is a member of the di-iron carboxylate family of proteins and catalyzes the hydroxylation of DMQ 6 [49] , enabling the final O-methylation step to produce Q 6 . We show that treatment with linolenic acid, but not oleic acid, increased Q 6 content, decreased DMQ 6 , and increased COQ7 and COQ3 RNA levels (Fig. 5) . Linolenic acid, a polyunsaturated fatty acid, is prone to autoxidation, and products of linolenic acid autoxidation are toxic to Q-deficient yeast, which can be rescued by restoration of Q 6 biosynthesis, or by the addition of exogenous Q 6 [32, 39] . These studies indicate that reduced Q (QH 2 ) serves as an essential lipid soluble antioxidant [50] . Because the hypersensitivity is observed in response to linolenic acid, but not oleic acid, (a monounsaturated fatty acid that is much more resistant to autoxidation), we propose that the increase in COQ7 and COQ3 RNA levels represents a stress response. Transcription of the yeast COQ5 gene is induced by growth in media containing oleic acid as sole carbon source [51] . However, in our studies treatment with oleic and linolenic acid were performed at lower concentrations of fatty acid and for only a short time (four hours). Our interpretation is that the linolenic acid-induced oxidative stress acts to degrade Q 6 , and the increase in DMQ 6 content and in COQ3 and COQ7 RNA levels represents a cellular stress-response to replenish Q 6 and provide antioxidant protection. Up-regulation of Q biosynthesis in response to vitamin E deficiency in rats has been previously demonstrated [24] . Notably, COQ7 gene expression was induced in small lung cancer cells following treatment with camptothecin [52] . The induction of COQ7, and resulting increase in cellular Q content was postulated to protect these cells from the stress caused by this topoisomerase I inhibitor. The yeast coq7 null mutant accumulates HHB (hydroxyl hexaprenyl benzoate) [26] . However, we show here that accumulation of newly synthesized DMQ 6 was induced in yeast coq7 null mutants by either addition of exogenous Q 6 or over-expression of the ABC1/COQ8 gene. The identity of DMQ 6 was verified by RP-HPLC/MS-MS analyses and identification of the parent ion and its fragmentation to a Figure 8 . Expression of yeast ABC1/COQ8 in multicopy facilitates production of DMQ 6 in the coq7 null mutant. CEN.MP3 -1A (coq7) null mutant yeast harbouring the ABC1/COQ8, COQ4, or empty vector on multicopy plasmids were cultured in SDc -Ura +glucose media for 16 hours. Total RNA was isolated from 200 x 10 6 cells and the content of COQ RNA was determined as previously described (Fig. S2B ). Band intensities were quantified by densitometry and plotted to calculate COQ RNA levels (A). Bars correspond to RNA content of COQ3, COQ4, COQ5, and ABC1/COQ8 (from white to black). The same cells (1 g wet weight) were collected and subjected to lipid extraction and separation by HPLC-ECD to detect lipid quinones (B). CEN.MP3 -1A with the empty vector pRS426 (coq7); with multicopy ABC1/COQ8 gene (coq7::ABC1); CEN.MP3 -1A with multicopy COQ4 (coq7::COQ4); Q 6 standard (25 ng).
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Vol. 66, 2009 Research Article 183 specific daughter ion. Furthermore, the production of DMQ 6 represents de novo synthesis because incubation of the coq7 null mutant in the presence of [ 14 C]-4-HB, the aromatic ring precursor of Q biosynthesis, led to the production 14 C-DMQ 6 , but only if the growth media was supplemented with exogenous Q 6 . This was a unique feature of the coq7 null mutant, as DMQ 6 was not detected when any of the other coq null mutants were cultured in the presence of exogenous Q 6 . Previous studies have shown that coq null mutants take up exogenously supplied Q 6 , with a restoration of respiratory electron transport. Supplemental Q 6 also acts to enhance steady state levels of the Coq3 and Coq4 polypeptides in the coq7 null mutant [27] , but does not affect COQ RNA levels (Fig. 7) . The results presented here indicate that Q 6 itself serves as a crucial lipid component and acts to facilitate formation of, and/or stabilize the Coq polypeptide Q 6 -biosynthetic complex. Our results also show that the Abc1/Coq8 polypeptide may serve a similar function, as its overexpression in the coq7 null mutant also allowed DMQ 6 to be produced. Aside from its function as a Q biosynthetic intermediate, what is the role of DMQ 6 ? Although postulated to function in respiratory electron transport or as an antioxidant [53] , this seems unlikely because yeast mutants that lack Q 6 and produce only DMQ 6 are respiratory defective and hypersensitive to oxidative stress [32, 44] . Several lines of evidence support the idea that DMQ 6 functions as a lipid component of the Coq polypeptide biosynthetic complex. Genetic evidence argues for the involvement of Q or a Q-intermediate in stabilizing the Coq3, Coq4, and Coq6 polypeptides [21] . DMQ 6 co-elutes with Coq3, Coq4 and Coq6 polypeptides as a high molecular weight complex when digitonin extracts of mitochondria are subjected to size exclusion chromatography [22] . Certain yeast coq7 point mutants (e.g. coq7E194K) have higher steady state levels of the Coq3 and Coq4 polypeptides and produce DMQ 6 . Although the enhanced Coq3 and Coq4 polypeptide levels may be due to the presence of the Coq7-E194K polypeptide, it is also possible some of the effects are due to the presence of the DMQ 6 intermediate itself [27] . Finally, we note that as an unsubstituted quinone, DMQ 6 is a potentially potent electrophile that may participate in Michael addition reactions and modify a variety of nucleophilic groups [54] . In fact, H 2 O 2 incubation does not affect the expression of COQ genes (Fig. 5B) but increases the Q 6 /DMQ 6 ratio (Fig. 5A) decreasing the DMQ 6 level. However, linolenic acid increases the expression of COQ7 and COQ3 genes together with an increased Q 6 /DMQ 6 ratio. This data point to a possible DMQ 6 degradation but only produced by H 2 O 2 . This differential behavior of both oxidative stress agents supports the idea that DMQ 6 may be protected by its accumulation in Q 6 biosynthetic complexes or in mitochondrial respiratory complexes containing endogenous Q 6 such the bc 1 complex. Thus, previous studies [32] have shown that in yeasts that only produce DMQ 6 , the incubation with linolenic acid increases the superoxide anion generation. This effect was not seen in wild type strains that produce both Q 6 and DMQ 6 . The protective effect can be deduced by the fact that DMQ 6 -producing strains cannot stabilize the bc 1 complex [32, 44] These results support a model where DMQ 6 biosynthesis in S. cerevisiae may take place in the complete absence of the Coq7 polypeptide, provided either the lipid product Q 6 is present, or Abc1/Coq8 is overexpressed. The role of Abc1/Coq8 polypeptide in Q biosynthesis is not known, but based on sequence motifs it has been identified as Hanks protein kinase [45] . Thus, Abc1/Coq8p is a candidate for the posttranslational regulation of Q biosynthesis. Overexpression of ABC1/COQ8 suppresses the effect of coq9 -1 mutation in S. cerevisiae [13] . Here we show ABC1/COQ8 overexpression allows coq7 null mutants to produce DMQ 6 . These results support the hypothesis that Coq7p regulates the rate of Q biosynthesis in yeast. A complex of Coq polypeptides serves to generate DMQ 6 , a prevalent Q-intermediate in log phase cells. The second phase of Q biosynthesis entails the hydroxylation of DMQ 6 by Coq7p, and subsequent Omethylation by Coq3p to form Q 6 . This idea was strongly supported by classical studies on coenzyme Q biosynthesis in rat liver, where DMQ 9 was accumulated during Q 9 biosynthesis analysis performed in liver slices [55] . Therefore, the final Q 6 synthesis requires the interaction of the Coq7 polypeptide with the first organized complex. The transitions between these two complexes may serve as a control point for Q 6 biosynthesis, and the accumulation of DMQ 6 itself may provide a reserve for the rapid supply of Q 6 .
